CClinicalTrials.gg
CompletedNCT04961073Updated Jan 13, 2022

Prevalence of Multiple Risk Behaviours and Its Association With Health Consequence

An observational study in Non-communicable Diseases, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by The University of Hong Kong · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
5,737
Ages
30 Years and older
Sex
All
01

Study summary

Hong Kong is facing an increasing threat of non-communicable diseases (NCDs), which is compounded by population aging. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age. WHO has identified four major behavioral risk factors - tobacco use, harmful use of alcohol, an unhealthy diet, and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in irregular physical activity, and quitting health-risk behaviors, such as smoking and harmful use of alcohol can help prevent NCDs and improve the quality of life and overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviors, despite their awareness of the associated health hazards.

Read the detailed description

Non-communicable diseases (NCDs), including cardiovascular diseases, cancers, diabetes and chronic respiratory diseases, are the most common and preventable causes of morbidity and mortality both globally and locally. According to the World Health Organization (WHO), 41 million (71%) of the 57.7 million global deaths each year are attributed to NCDs. NCDs are often associated with older age groups, but evidence shows that more than 15 million of all deaths attributed to NCDs occur between the ages of 30 and 69 years. The total number of annual deaths of NCDs will further increase to 55 million by 2030 unless urgent preventive measures are taken.

Hong Kong is facing an increasing threat of NCDs, which is compounded by population ageing. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age.

WHO has identified four major behavioural risk factors - tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in regular physical activity, and quitting health-risk behaviours, such as smoking and harmful use of alcohol can help prevent NCDs and improve quality of life and the overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviours, despite their awareness of the associated health hazards. Our previous studies showed that many smokers continued to smoke even after receiving a diagnosis of cancer, diabetes or cardiovascular disease. In addition, health risk behaviours co-occur in clusters and that many people exhibit multiple risk behaviours. A sample of 16,818 adults from the 1998 US National Health Interview Survey revealed that 52% had two or more risk behaviours, including physical inactivity, overweight, cigarette smoking and risky drinking. Our previous study in Hong Kong also found associations between smoking and physical inactivity, an unhealthy diet and alcohol consumption. People with multiple health risk behaviours are usually associated with a higher increased risk of NCDs and face more challenges in the adoption of a healthy lifestyle than those with a single health risk behaviour. A review of the literature reveals that most interventions have been developed and evaluated targeted at people with single risk behaviour rather than multiple risk behaviours. It is crucial therefore to develop and evaluate appropriate interventions that targeting people with multiple risk behaviours with the aim to help them quit health-risk behaviours and adopt a healthy lifestyle, either sequentially or concurrently. First, however, a thorough understanding of the clustering of multiple health risk behaviours and the factors associated with such behaviours are crucial before any appropriate interventions can be developed and evaluated. The aim of the study is to investigate the prevalence of multiple risk behaviours and their association with health consequences among people aged 30 years or above. The objectives of the study are:

  1. To investigate the clustering patterns of multiple health risk behaviours;
  2. To identify factors associated with multiple risk behaviours; and
  3. To find out the association between risk behaviours and non-communicable diseases.
02

Conditions studied

  • Non-communicable Diseases

Keywords

  • Risk behaviours
  • Health consequence
  • Non-communicable diseases
03

In context

Noncommunicable Diseases

128 studies on the registry are indexed under Noncommunicable Diseases; 44 are open to participants now.

This study's enrollment of 5,737 is above the median of 1,748 across 43 observational studies indexed under Noncommunicable Diseases.

Browse Noncommunicable Diseases studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

A randomized sample of Hong Kong Chinese adults who aged 30 years or above will be recruited at hotspots in eighteen districts in Hong Kong.

Inclusion criteria

  • Aged 30 years or above
  • Able to speak Cantonese

Exclusion criteria

Exclusion Criteria:

  • Unable to speak Cantonese
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
5,737 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Demographic data questionnaire

    Personal demographic characteristics (e.g. sex, age, educational attainment, marital status, occupation, household income)

    Time frame: Baseline

  2. History of NCDs questionnaire

    NCDs characteristics

    Time frame: Baseline

  3. Medical check-up questionnaire

    History of medical check-up

    Time frame: Baseline

  4. Diet habits questionnaire

    Personal habits of diet (e.g. daily vegetable and fruit intake)

    Time frame: Baseline

  5. Physical activity questionnaire

    Personal habits of diet and physical activity (e.g. daily physical activity amount and time)

    Time frame: Baseline

  6. Unhealthy behaviors questionnaire

    Habits of risky behaviors (e.g. smoking/ alcohol habits, daily cigarette consumption)

    Time frame: Baseline

  7. Knowledge and awareness of COVID-19 and NCDs questionnaire

    Knowledge and awareness of COVID-19 and NCDs (e.g. knowledge about relationship between smoking and COVID, relationship between NCDs and COVID, etc)

    Time frame: Baseline

07

Study locations

1 site
  • The University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: Yes — The relevant anonymized patient level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04961073
Lead sponsor
The University of Hong Kong
Responsible party
Sponsor
First posted
Jul 14, 2021
Start date
Jun 21, 2021
Primary completion
Aug 31, 2021
Completion
Aug 31, 2021
Last update
Jan 13, 2022

Study contacts

Ho Cheung William Li, PhD
principal investigator · School of Nursing, the University of Hong Kong

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion